1.53
price up icon6.25%   0.09
 
loading
Precedente Chiudi:
$1.44
Aprire:
$1.55
Volume 24 ore:
2.00M
Relative Volume:
10.12
Capitalizzazione di mercato:
$3.23M
Reddito:
-
Utile/perdita netta:
$-20.26M
Rapporto P/E:
-0.1792
EPS:
-8.54
Flusso di cassa netto:
$-8.25M
1 W Prestazione:
-56.16%
1M Prestazione:
-65.31%
6M Prestazione:
-85.21%
1 anno Prestazione:
-95.05%
Intervallo 1D:
Value
$1.43
$1.58
Intervallo di 1 settimana:
Value
$1.35
$4.19
Portata 52W:
Value
$1.35
$75.60

Oragenics Inc Stock (OGEN) Company Profile

Name
Nome
Oragenics Inc
Name
Telefono
813-286-7900
Name
Indirizzo
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Name
Dipendente
6
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
OGEN's Discussions on Twitter

Confronta OGEN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
OGEN
Oragenics Inc
1.53 3.23M 0 -20.26M -8.25M -8.54
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Oragenics Inc Borsa (OGEN) Ultime notizie

pulisher
Jun 18, 2025

Major Shareholder Odyssey Health Sells Oragenics Stock! - TipRanks

Jun 18, 2025
pulisher
Jun 11, 2025

Future of Oral Probiotic Supplements | Innovations in Oral - openPR.com

Jun 11, 2025
pulisher
Jun 11, 2025

Oragenics Inc. to Showcase Concussion Treatment Candidate at Major 2025 Conferences - citybuzz -

Jun 11, 2025
pulisher
Jun 10, 2025

Oragenics to Present at 2025 BIO International Convention and At - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Oragenics, Inc. to Present ONP-002 at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - Nasdaq

Jun 10, 2025
pulisher
Jun 10, 2025

GlobeNewswire by Notified - The Manila Times

Jun 10, 2025
pulisher
Jun 10, 2025

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium | OGEN Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - The Manila Times

Jun 10, 2025
pulisher
Jun 10, 2025

Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews

Jun 10, 2025
pulisher
Jun 10, 2025

Oragenics to Present at 2025 BIO International Convention - GlobeNewswire

Jun 10, 2025
pulisher
Jun 10, 2025

Top stock gains: US stocks posting the highest gains today - Yahoo

Jun 10, 2025
pulisher
Jun 06, 2025

Rocket Lab Corporation (RKLB): A Bull Case Theory - Yahoo

Jun 06, 2025
pulisher
Jun 06, 2025

Upstart Holdings, Inc. (UPST): A Bull Case Theory - Yahoo

Jun 06, 2025
pulisher
Jun 05, 2025

Vireo Growth Inc. Announces Closing of Proper Brands Acquisition in Missouri - Yahoo

Jun 05, 2025
pulisher
Jun 05, 2025

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea - Yahoo

Jun 05, 2025
pulisher
Jun 04, 2025

Pre-market Movers: STSS, SGMT, NIVF, OGEN... - RTTNews

Jun 04, 2025
pulisher
Jun 04, 2025

Top Premarket Decliners - MarketScreener

Jun 04, 2025
pulisher
Jun 03, 2025

Oragenics (OGEN) Resumes Trading: Key Insights for Investors | O - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Oragenics (OGEN) Trading Paused Due to High Volatility | OGEN St - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Oragenics (OGEN) Resumes Trading: Key Insights for Investors | OGEN Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 02, 2025

ABB acquires Bel Products Inc. to expand enclosures portfolio in North America - Yahoo

Jun 02, 2025
pulisher
Jun 02, 2025

Pre-market Movers: LYRA, INM, OGEN, VERA... - RTTNews

Jun 02, 2025
pulisher
Jun 02, 2025

Oral Probiotics Supplements Gain Popularity in Digestive - openPR.com

Jun 02, 2025
pulisher
May 31, 2025

OGEN stock touches 52-week low at $0.12 amid sharp annual decline By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 30, 2025

OGEN stock touches 52-week low at $0.12 amid sharp annual decline - Investing.com Australia

May 30, 2025
pulisher
May 29, 2025

Oragenics announces reverse stock split to begin June 3 By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 28, 2025

Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews

May 28, 2025
pulisher
May 28, 2025

Oragenics (OGEN) Announces One-for-Thirty Reverse Stock Split | - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Oragenics announces reverse stock split to begin June 3 - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

Oragenics Announces Reverse Stock Split to Boost Share Price - TipRanks

May 28, 2025
pulisher
May 28, 2025

Oragenics (OGEN) Announces One-for-Thirty Reverse Stock Split | OGEN Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Worksport Secures ISO 9001 Certification at U.S. Factory, Unlocking Revenue & OEM Growth Pathways - The Manila Times

May 28, 2025
pulisher
May 20, 2025

Oragenics Hosts Neurotrauma Medicine Webinar Presentation - TipRanks

May 20, 2025
pulisher
May 15, 2025

Oragenics (NYSE:OGEN) Earns Sell Rating from Analysts at StockNews.com - Defense World

May 15, 2025
pulisher
May 14, 2025

Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

TotalEnergies sells 50% stake in Polish biogas company to HitecVision - Yahoo

May 14, 2025
pulisher
May 13, 2025

Oragenics (OGEN) Gains Approval for Phase II Trial of Neuroprote - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Oragenics gains Australia’s nod for concussion therapy trial - Investing.com Australia

May 13, 2025
pulisher
May 13, 2025

Oragenics gains Australia’s nod for concussion therapy trial By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Oragenics, Inc. Announces Approval to Initiate Phase II Concussi - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia | OGEN Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Oragenics, Inc. to Host Management Update Webinar on May - GlobeNewswire

May 13, 2025
pulisher
May 12, 2025

Oragenics, Inc. to Host Management Update Webinar on May 20, 202 - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision | OGEN Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Oragenics, Inc. to Host Webinar on ONP-002 and Addressing Unmet Needs in Concussion Treatment - Nasdaq

May 12, 2025
pulisher
May 12, 2025

CSW Industrials Announces Date for Fiscal Fourth Quarter and Full Year 2025 Earnings Release Conference Call - The Manila Times

May 12, 2025
pulisher
May 10, 2025

Oragenics: Q1 Earnings Snapshot - New Haven Register

May 10, 2025

Oragenics Inc Azioni (OGEN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Oragenics Inc Azioni (OGEN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Odyssey Health, Inc.
10% Owner
Jun 17 '25
Sale
4.46
2,000
8,920
5,044
Odyssey Health, Inc.
10% Owner
Jun 16 '25
Sale
4.45
5,000
22,250
7,044
Odyssey Health, Inc.
10% Owner
Jun 13 '25
Sale
4.27
5,000
21,350
12,044
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Capitalizzazione:     |  Volume (24 ore):